Table 4 Sociodemographic and clinical information for Huntington’s disease gene-carriers at baseline.
From: Cognitive engagement may slow clinical progression and brain atrophy in Huntington’s disease
Premanifest | Manifest | HD combined cohort | |
|---|---|---|---|
N | 21 | 24 | 45 |
Sex (males/females) | 3/18 | 11/13 | 14/31 |
Age (years) | 35.71 ± 8.8 (25, 59) | 50.21 ± 9.7 (35, 69) | 43.44 ± 11.8 (25, 69) |
Education | 13.33 ± 4.0 (8, 19) | 12.08 ± 4.0 (6, 18) | 12.67 ± 4.0 (6, 19) |
CAP | 76.25 ± 16.4 (47.37, 122.01) | 107.44 ± 17.6 (73.68, 139.39) | 92.89 ± 23.1 (47.37, 139.39) |
Estimated age of onset* | 47.02 + 8.8 (32.59, 62.64) | – | – |
Estimated years to onset† | 11.31 ± 8.3 (-8.67, 30.06) | – | – |
CRQ | 14.38 ± 4.0 (6, 21) | 10.88 ± 3.9 (4, 18) | 12.51 ± 4.3 (4, 21) |
UHDRS-motor | 1.30 ± 2.6 (0, 10) N = 20 | 21.17 ± 12.7 (4, 58) | 12.14 ± 13.8 (0, 58) N = 44 |
UHDRS-cogscore | 134.40 ± 29.8 (100, 200) N = 20 | 77.96 ± 26.9 (21, 117) N = 23 | 104.21 ± 39.9 (21, 200) N = 43 |
F-A-S test | 39.30 ± 14.2 (17, 69) | 24.09 ± 9.7 (6, 46) | 31.12 ± 14.1 (6, 69) |
Symbol Digit Modalities | 47.55 ± 9.3 (31, 64) | 28.17 ± 11.1 (11, 50) | 37.19 ± 14.1 (11, 64) |
Stroop interference | 47.55 ± 13.1 (28, 77) | 25.70 ± 10.8 (4, 47) | 35.86 ± 16.1 (4, 77) |
PBA-s | 21.00 ± 25.6 (0, 87) | 18.75 ± 16.0 (1, 67) | 19.80 ± 20.8 (0, 87) |
Mood | 8.52 ± 9.7 (0, 28) | 4.71 ± 7.9 (0, 34) | 6.64 ± 8.9 (0, 34) |
Apathy | 3.29 ± 5.5 (0, 16) | 5.63 ± 5.2 (0, 16) | 4.53 ± 5.4 (0, 16) |
Irritability/aggression | 3.10 ± 6.4 (0, 25) | 2.71 ± 4.3 (0, 16) | 2.89 ± 5.4 (0, 25) |
Psychosis | 1.33 ± 3.7 (0, 16) | 0.00 ± 0.0 (0, 0) | 0.62 ± 2.6 (0, 16) |
Dysexecutive behaviors | 4.76 ± 8.0 (0, 28) | 4.67 ± 4.4 (0, 18) | 4.71 ± 6.3 (0, 28) |